Attend
Read
Watch
Listen
About Us
Work with Us
Events
Contact
Weekly Digest
Job Board
synbiobeta 2021
live
OCTOBER 4 - 6
May 23-25
Oakland Marriott, California
Learn More
Because Being In The Same Room Is Better Than Being On The Same Zoom!
@ the Oakland Marriott City Center, Oakland CA
Back
Contact
What Is Synthetic Biology?
About BWB
Our Staff
Our Writers
Back
Contact
Advertise
Sponsors
Exhibitors
Conflict of Interest
Back
Contact
Job Board
Back
Contact
Current Event
Conferences
Courses
Industry Tours
Attend
Read
Watch
Listen
About Us
Weekly Digest
Site Search
Close
Become a Member
Insider
Free
Access to Premium Articles
Pick your content preferences
Industry Insider Newsletter
Invitation to Panel
Signup
Insider Premium
$3/month
Access to Premium Articles
Pick your content preferences
Industry Insider Newsletter
Invitation to Panel
Signup
By using this website, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our
Privacy Policy
for more information.
Preferences
Deny
Accept
Digests
November 9, 2022
Twist Bioscience’s new President and COO, a virus-resistant organism, and more
November 2, 2022
Solugen raises $200M, Recursion $150M, and Time BioVentures wraps up its $100M funding round
October 26, 2022
Prime’s $175M IPO, Hoxton’s $22M, Nourish’s $28.6M raise + SynBioBeta’s early bird ends Monday
October 19, 2022
3 new super foods launched this week, IARPA/ Ginkgo biosecurity partnership + GM invests in MycoWorks
October 12, 2022
Ginkgo inks $144M deal with Merck, Biosyntia raises 17.5 mEUR
October 5, 2022
Illumina's $200 genome is here, LanzaTech's $500M and Geno's $120M deal, more inside
September 27, 2022
Colossal Biosciences launches Form Bio with a $30M Series A, Cell based meat company Orbillion Bio to go to market in 35 countries
September 21, 2022
Codex launches the BioXp™ 9600 system + $43.5m for Novome, $165m for Capstan
September 14, 2022
Live from the White House Bioeconomy Summit + Synthetic Biology in Africa
September 7, 2022
ArsenalBio’s $220M, Think Bioscience’s $17M, Jay Keasling’s anti-cancer drug
Previous
Next
Subscribe Below
Complete the form below to subscribe to our digest